perseitol: RN given refers to (D-glycero-D-galacto)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
perseitol : A heptitol that is heptane-1,2,3,4,5,6,7-heptol that has R-configuration at positions 2, 3, 4 and 5, and S-configuration at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 441436 |
| CHEBI ID | 8029 |
| SCHEMBL ID | 532907 |
| SCHEMBL ID | 4245457 |
| MeSH ID | M0085239 |
| Synonym |
|---|
| perseitol |
| C08255 |
| 527-06-0 |
| (2s,3r,5r,6r)-heptane-1,2,3,4,5,6,7-heptol |
| unii-565po82at6 |
| nsc 1976 |
| einecs 208-406-1 |
| 565po82at6 , |
| l-glycero-d-manno-heptitol |
| CHEBI:8029 |
| (2r,3r,4r,5r,6s)-heptane-1,2,3,4,5,6,7-heptol |
| perseit |
| CCG-214144 |
| SCHEMBL532907 |
| SCHEMBL4245457 |
| W-202992 |
| (2r,3r,5r,6s)-heptane-1,2,3,4,5,6,7-heptol |
| Q27089371 |
| Q11815734 |
| perseitol from avocardo |
| BS-28631 |
| AKOS040759766 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " Bioavailability was calculated as F=AUC by gavage/AUC by injection, where AUC is the area under the curve of plasma probe concentration vs." | ( Intestinal passive absorption of water-soluble compounds by sparrows: effect of molecular size and luminal nutrients. Caviedes-Vidal, E; Chediack, JG; Fasulo, V; Karasov, WH; Yamin, LJ, 2003) | 0.32 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11 | 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.14%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (92.86%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||